CAS-551-16-6

DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica

US DMF filings indicate a robust API industry, with multiple first-to-file challenges

This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at

Novartis’ plant shut down creates urgency to find alternatives to Chinese APIs

With Novartis shutting two plants in Germany and one in India by 2016-end, the global reliance on Ch